Found: 6
Select item for more details and to access through your institution.
Lower Fracture Rates in Patients Treated with Radium-223, Abiraterone or Enzalutamide, When Given Concurrently with Bone Health Agents: A Real-World Analysis.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 5, p. 399, doi. 10.1016/j.clgc.2022.04.015
- By:
- Publication type:
- Article
Direct T Cell Activation via CD40 Ligand Generates High Avidity CD8<sup>+</sup> T Cells Capable of Breaking Immunological Tolerance for the Control of Tumors.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0093162
- By:
- Publication type:
- Article
Xenogeneic Human p53 DNA Vaccination by Electroporation Breaks Immune Tolerance to Control Murine Tumors Expressing Mouse p53.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0056912
- By:
- Publication type:
- Article
Detectable end of radiation prostate specific antigen assists in identifying men with unfavorable intermediate‐risk prostate cancer at high risk of distant recurrence and cancer‐specific mortality.
- Published in:
- Prostate, 2018, v. 78, n. 8, p. 623, doi. 10.1002/pros.23507
- By:
- Publication type:
- Article
Serial ctDNA analysis predicts clinical progression in patients with advanced urothelial carcinoma.
- Published in:
- British Journal of Cancer, 2022, v. 126, n. 3, p. 430, doi. 10.1038/s41416-021-01648-8
- By:
- Publication type:
- Article
Serial ctDNA analysis predicts clinical progression in patients with advanced urothelial carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article